143 related articles for article (PubMed ID: 1688076)
21. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica.
Han YQ; Huang ZM; Yang XB; Liu HZ; Wu GX
J Ethnopharmacol; 2008 Jun; 118(1):148-53. PubMed ID: 18495393
[TBL] [Abstract][Full Text] [Related]
22. In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus.
Leung KT; Chiu LC; Lam WS; Li Y; Sun SS; Ooi VE
Phytother Res; 2006 Oct; 20(10):911-4. PubMed ID: 16892461
[TBL] [Abstract][Full Text] [Related]
23. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.
Wang WN; Yang XB; Liu HZ; Huang ZM; Wu GX
Acta Pharmacol Sin; 2005 May; 26(5):587-92. PubMed ID: 15842778
[TBL] [Abstract][Full Text] [Related]
24. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
Zhao G; Yin Z; Dong J
J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
[TBL] [Abstract][Full Text] [Related]
25. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro.
Wang GF; Shi LP; Ren YD; Liu QF; Liu HF; Zhang RJ; Li Z; Zhu FH; He PL; Tang W; Tao PZ; Li C; Zhao WM; Zuo JP
Antiviral Res; 2009 Aug; 83(2):186-90. PubMed ID: 19463857
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of the Indian strain of duck hepatitis B virus (DHBV) and development of a carrier duck colony for antiviral drug testing.
Munshi A; Mehrotra R; Panda SK
Trop Gastroenterol; 1994; 15(2):77-85. PubMed ID: 7831721
[TBL] [Abstract][Full Text] [Related]
27. Effect of 3'-azido-3'-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro.
Haritani H; Uchida T; Okuda Y; Shikata T
J Med Virol; 1989 Dec; 29(4):244-8. PubMed ID: 2559951
[TBL] [Abstract][Full Text] [Related]
28. Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.
Yokota T; Konno K; Chonan E; Mochizuki S; Kojima K; Shigeta S; de Clercq E
Antimicrob Agents Chemother; 1990 Jul; 34(7):1326-30. PubMed ID: 2201250
[TBL] [Abstract][Full Text] [Related]
29. [The inhibitory effect of compound liuyuexue on DHBV DNA].
Zhang SJ; Lin J; Jiang WZ; Huang CX; Huamg RB
Zhong Yao Cai; 2007 Feb; 30(2):191-3. PubMed ID: 17571772
[TBL] [Abstract][Full Text] [Related]
30. [Experimental study on anti-DHBV effect of yu gan capsules].
Tan X; Zhang A; Yu W; Cen Y; Zhang F
Zhong Yao Cai; 2005 Aug; 28(8):679-81. PubMed ID: 16379421
[TBL] [Abstract][Full Text] [Related]
31. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugs.
Galle PR; Theilmann L
Arzneimittelforschung; 1990 Dec; 40(12):1380-2. PubMed ID: 2095136
[TBL] [Abstract][Full Text] [Related]
33. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and structure relationships of new N,N',N",N"'-tetrakis (omega-amino alkyl) tetraazamacrocycles.
Trabaud C; Dessolin J; Camplo M; Hantz O; Zoulim F; Borel C; Meyer M; Pepe G; Chermann JC; Kraus JL
Antivir Chem Chemother; 1998 Jan; 9(1):73-84. PubMed ID: 9875379
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L.
Li J; Huang H; Feng M; Zhou W; Shi X; Zhou P
Antiviral Res; 2008 Aug; 79(2):114-20. PubMed ID: 18423640
[TBL] [Abstract][Full Text] [Related]
37. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides.
Suzuki S; Lee B; Luo W; Tovell D; Robins MJ; Tyrrell DL
Biochem Biophys Res Commun; 1988 Nov; 156(3):1144-51. PubMed ID: 3190693
[TBL] [Abstract][Full Text] [Related]
39. Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
Ying C; Tan S; Cheng YC
Antivir Chem Chemother; 2010; 21(2):97-103. PubMed ID: 21107018
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine.
Severini A; Liu XY; Wilson JS; Tyrrell DL
Antimicrob Agents Chemother; 1995 Jul; 39(7):1430-5. PubMed ID: 7492080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
